Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Epizyme, Inc. (EPZM) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/09/2022 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Epizyme Reports Second Quarter 2022 Financial Results and Provides Business Update"
06/27/2022 8-K Quarterly results
05/24/2022 8-K Quarterly results
05/19/2022 8-K Quarterly results
05/10/2022 8-K Quarterly results
04/06/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/15/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Epizyme Announces Executive Appointment and Provides Tazemetostat Clinical Update"
03/01/2022 8-K Quarterly results
01/27/2022 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Underwriting Agreement, by and among the Company and Jefferies, LLC, as representative of the several Underwriters",
"Opinion of Wilmer Cutler Pickering Hale and Dorr LLP"
01/10/2022 8-K Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Epizyme Provides Business Highlights, Preliminary Fourth Quarter and Full Year 2021 Financials and Clinical Trial Updates"
12/22/2021 8-K Termination of a Material Definitive Agreement  Interactive Data
11/18/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Epizyme Announces Updates to Its Board of Directors"
11/09/2021 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Epizyme Reports Third Quarter 2021 Financial Results and Provides Business Update"
10/29/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/16/2021 8-K Quarterly results
08/09/2021 8-K Quarterly results
06/28/2021 8-K Quarterly results
06/16/2021 8-K Quarterly results
05/06/2021 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Epizyme Provides Business Update and Reports First Quarter 2021 Financial Results"
02/23/2021 8-K/A Quarterly results
02/23/2021 8-K Quarterly results
12/23/2020 8-K Termination of a Material Definitive Agreement  Interactive Data
11/06/2020 8-K Quarterly results
Docs: "Epizyme Reports Business Progress and Third Quarter 2020 Financial Results"
08/04/2020 8-K Quarterly results
06/03/2020 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/04/2020 8-K Quarterly results
04/03/2020 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
02/24/2020 8-K Quarterly results
01/06/2020 8-K Results of Operations and Financial Condition, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ...
Docs: "Epizyme Announces Exercise of $50 Million Option with Royalty Pharma and Highlights Key 2020 Initiatives to Build Long-Term Value"
11/04/2019 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
10/30/2019 8-K Quarterly results
09/04/2019 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549",
"Epizyme Announces Board of Director Appointments to Support Continued Evolution and Growth"
08/19/2019 8-K Entry into a Material Definitive Agreement  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549"
08/09/2019 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy